CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
Physical Therapyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02239601
NCT02239601N/ACompleted

Chemotherapy - Induced Peripheral Neuropathy (CIPN). Could There be a Role for Physical Therapy Treatment?

CancerCare Manitoba·interventional·Posted Sep 15, 2014·Updated Oct 9, 2019

In Brief

A clinical study evaluating Physical Therapy for Breast Cancer and Peripheral Neuropathy, Secondary to Drugs or Chemicals. Completed, enrolled 61 participants across 1 site.

Detailed Summary

The cause of Chemotherapy-Induced Peripheral Neuropathy (CIPN) is still unknown. An estimated 55-60% of patients will experience lasting symptoms affecting function for years post-treatment. Physical therapy is an established, effective treatment for entrapped nerves and neuropathic pain. This study sought to identify additional risk factors and provide evidence for the role of physical therapy in the treatment of CIPN.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 15, 2014
Enrollment StartDec 1, 2014
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.8 years ago

Interventions

Physical Therapyother

Physical therapy assessment and treatment for any positive signs of nerve entrapment prior to chemotherapy including nerve gliding exercises, education and splinting. A home program was provided and continued throughout chemotherapy treatment